Biopharmaceutical News and Research

RSS
CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments

NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments

PAREXEL partners with Datavant to enhance clinical study design and generate real-world evidence

PAREXEL partners with Datavant to enhance clinical study design and generate real-world evidence

Research finds physical connection between the brain's fluid reservoirs and meningeal lymphatics

Research finds physical connection between the brain's fluid reservoirs and meningeal lymphatics

LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs

LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs

Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests

Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

PAREXEL launches Patient Innovation Center to improve drug development process

PAREXEL launches Patient Innovation Center to improve drug development process

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Sartorius Stedim Biotech and Repligen collaborate to create novel perfusion-enabled bioreactors

Sartorius Stedim Biotech and Repligen collaborate to create novel perfusion-enabled bioreactors

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Celmatix and Ferring announce genomics collaboration aimed at uncovering new insights into ovarian biology

Celmatix and Ferring announce genomics collaboration aimed at uncovering new insights into ovarian biology

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

EC grants marketing authorization for ONPATTRO (patisiran) in Europe